Respiratory Syncytial Virus (RSV) Completed Phase 1 / 2 Trials for Meningococcal polysaccharide vaccine group W-135 (DB13887)

Also known as: Respiratory Syncytial Viruses / Respiratory Syncytial Virus / Viruses, Respiratory Syncytial / RSV

IndicationStatusPhase
DBCOND0036542 (Respiratory Syncytial Virus (RSV))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03606512A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of AgePrevention